Chronic Pain

Enrollment in medical cannabis programs increased overall from 2020 to 2022, but it decreased in most states where nonmedical cannabis use became legal, research showed.

Individuals with cancer reported significantly reduced pain immediately following a 10-minute virtual reality (VR) session, study results published in Cancer showed.

SCOTTSDALE, Ariz. — Understanding the science of pain can help rheumatologists better manage fibromyalgia and other chronic conditions, according to a presenter at the Basic and Clinical Immunology for the Busy Clinician symposium.

Silo Pharma will advance a portfolio of four drugs in its 2024 clinical pipeline, targeting conditions related to mental health, chronic pain and neurology.

An intervention failed to increase patient activation, but it helped to improve depression, patient portal management and other health measures among patients with chronic pain on long-term opioids, according to a randomized trial.

An Ohio-based medical device company has secured $85 million in financing to advance a pain management system targeting the central nervous system to help those who have undergone surgery or sustained damage from other events or conditions.

Gabapentinoid use has continued to increase in the last several years despite a “dearth of evidence” that supports the drug’s use, according to researchers.

Medical cannabis use for chronic pain may confer increased risk for de novo arrhythmia compared with nonuse or other treatments for chronic pain, researchers in Denmark reported.

In June 2022, PBS debuted Below the Belt, a documentary executive produced by Hillary Rodham Clinton. This thought-provoking film introduced viewers to four remarkable women grappling with the debilitating effects of endometriosis.

In this video from the American Academy of Physical Medicine and Rehabilitation Meeting, Adam Tenforde, MD, discussed the high prevalence of osteoarthritis and total joint arthroplasty among former football players.